3-methyl-1,2-dihydroquinolin-2-one

CAS No. 2721-59-7

3-methyl-1,2-dihydroquinolin-2-one( —— )

Catalog No. M28403 CAS No. 2721-59-7

3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 56 In Stock
5MG 70 In Stock
10MG 105 In Stock
25MG 179 In Stock
50MG 258 In Stock
100MG 365 In Stock
200MG 496 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-methyl-1,2-dihydroquinolin-2-one
  • Note
    Research use only, not for human use.
  • Brief Description
    3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
  • Description
    3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2721-59-7
  • Formula Weight
    159.188
  • Molecular Formula
    C10H9NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cc2ccccc2[nH]c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Eyer P, Hell W. The metabolism of 3-benzoylpyridine. Xenobiotica. 1983 Nov;13(11):649-59. PubMed PMID: 6673376.
molnova catalog
related products
  • Piflufolastat

    Piflufolastat (DCFPYL) is a PET imaging agent for prostate cancer PSMA. It is a fluorinated prostate-specific membrane antigen (PSMA) preparation.

  • BRM/BRG1 ATP Inhibit...

    BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.

  • Trotabresib

    Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors.